Johan Noble

1.1k total citations
78 papers, 641 citations indexed

About

Johan Noble is a scholar working on Transplantation, Nephrology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Johan Noble has authored 78 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Transplantation, 23 papers in Nephrology and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Johan Noble's work include Renal Transplantation Outcomes and Treatments (44 papers), Renal Diseases and Glomerulopathies (20 papers) and Complement system in diseases (11 papers). Johan Noble is often cited by papers focused on Renal Transplantation Outcomes and Treatments (44 papers), Renal Diseases and Glomerulopathies (20 papers) and Complement system in diseases (11 papers). Johan Noble collaborates with scholars based in France, Thailand and Italy. Johan Noble's co-authors include Lionel Rostaing, Paolo Malvezzi, Thomas Jouvé, Bénédicte Janbon, Anthony L. Cunningham, G. Fiard, Françoise Stanke‐Labesque, Dominique Masson, Mathilde Bugnazet and Xavier Fonrose and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Johan Noble

69 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Noble France 16 340 171 131 129 109 78 641
Jatin Kothari India 6 405 1.2× 205 1.2× 138 1.1× 160 1.2× 85 0.8× 19 651
Núria Montero Spain 16 363 1.1× 242 1.4× 167 1.3× 78 0.6× 110 1.0× 58 708
Bénédicte Janbon France 15 266 0.8× 163 1.0× 111 0.8× 79 0.6× 87 0.8× 39 518
Kwaku Marfo United States 13 337 1.0× 174 1.0× 107 0.8× 190 1.5× 108 1.0× 31 675
Marisa Mir Spain 17 420 1.2× 289 1.7× 148 1.1× 112 0.9× 154 1.4× 46 828
Lucile Amrouche France 13 374 1.1× 263 1.5× 148 1.1× 101 0.8× 108 1.0× 32 674
David J. Conti United States 14 240 0.7× 239 1.4× 182 1.4× 67 0.5× 81 0.7× 26 749
Patricia Hirt‐Minkowski Switzerland 17 474 1.4× 272 1.6× 170 1.3× 110 0.9× 164 1.5× 42 740
Santosh Potdar United States 9 287 0.8× 253 1.5× 113 0.9× 92 0.7× 119 1.1× 20 644
J. Xing United States 7 542 1.6× 234 1.4× 189 1.4× 188 1.5× 40 0.4× 12 726

Countries citing papers authored by Johan Noble

Since Specialization
Citations

This map shows the geographic impact of Johan Noble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Noble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Noble more than expected).

Fields of papers citing papers by Johan Noble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Noble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Noble. The network helps show where Johan Noble may publish in the future.

Co-authorship network of co-authors of Johan Noble

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Noble. A scholar is included among the top collaborators of Johan Noble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Noble. Johan Noble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bin, Sofia, Irene Ramos, Johan Noble, et al.. (2025). Erythropoietin prolongs graft survival in mice by counteracting trained immunity. American Journal of Transplantation. 26(2). 249–262.
2.
Noble, Johan, et al.. (2025). Transition from preclinical to clinical application of CTLA4-Ig co-stimulation blockage in beta-cell replacement therapy. Transplantation Reviews. 39(2). 100913–100913.
3.
Noble, Johan, Giorgia Comai, Céline Dard, et al.. (2025). Tocilizumab-Based Treatment of Microvascular Inflammation in Kidney Transplant Recipients: A Retrospective Study. Transplant International. 38. 14502–14502.
4.
Malvezzi, Paolo, et al.. (2024). Unraveling complexity: morbidity factors in elderly kidney transplant recipients. Clinical Kidney Journal. 17(8). sfae182–sfae182.
5.
Germi, Raphaële, Mathilde Bugnazet, Paolo Malvezzi, et al.. (2024). Evaluation of Torque Teno Virus DNA Load as a Predictive Biomarker in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to Belatacept. Kidney International Reports. 9(6). 1718–1729. 6 indexed citations
6.
Noble, Johan, Zuzana Macek Jílková, Caroline Aspord, et al.. (2024). Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation. Transplant International. 37. 12330–12330. 5 indexed citations
7.
Chavarot, Nathalie, Hannah Kaminski, Hélène Lazareth, et al.. (2024). Similar Efficacy in Belatacept-Converted Kidney Transplant Recipients With Steroid-Avoiding Regimen. Kidney International Reports. 10(3). 803–815. 1 indexed citations
8.
Rostaing, Lionel, et al.. (2023). Adverse Drug Events after Kidney Transplantation. Journal of Personalized Medicine. 13(12). 1706–1706. 6 indexed citations
9.
Noble, Johan, Anaïs Dartevel, Céline Dard, et al.. (2023). Fatal HSV-2 primary infection most likely acquired by kidney transplantation: A case report. International Journal of Antimicrobial Agents. 61(5). 106769–106769. 1 indexed citations
10.
Jouvé, Thomas, et al.. (2023). Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study. Journal of Clinical Medicine. 12(2). 424–424. 5 indexed citations
11.
Jouvé, Thomas, et al.. (2022). Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review. Frontiers in Immunology. 13. 839380–839380. 25 indexed citations
12.
Noble, Johan, Dominique Masson, G. Fiard, et al.. (2021). Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation. Journal of Clinical Medicine. 10(6). 1316–1316. 15 indexed citations
13.
Noble, Johan, Dominique Masson, Mathilde Bugnazet, et al.. (2021). Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates. Transplantation Direct. 7(5). e690–e690. 22 indexed citations
14.
Jouvé, Thomas, Caroline Laheurte, Johan Noble, et al.. (2021). Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates. American Journal of Transplantation. 22(1). 71–84. 25 indexed citations
15.
Noble, Johan, et al.. (2021). Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review. Journal of Clinical Medicine. 10(19). 4359–4359. 10 indexed citations
16.
Noble, Johan, Mathilde Bugnazet, Bénédicte Janbon, et al.. (2020). Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review. Blood Purification. 49(3). 322–333. 7 indexed citations
17.
Jouvé, Thomas, et al.. (2020). Impact of Immunosuppressive Strategies on Post–Kidney Transplantation Thrombocytopenia. Transplantation Proceedings. 53(3). 941–949. 1 indexed citations
18.
19.
Noble, Johan, Thomas Jouvé, Lionel Rostaing, & Paolo Malvezzi. (2018). Advagraf® with or without an induction therapy for de novo kidney-transplant recipients. Expert Review of Clinical Immunology. 14(6). 461–467. 2 indexed citations
20.
Gatault, Philippe, Johan Noble, Catherine S. Forconi, et al.. (2018). CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells. American Journal of Transplantation. 18(8). 1904–1913. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jatin Kothari Breakdown of academic impact, for papers by Núria Montero Breakdown of academic impact, for papers by Bénédicte Janbon Breakdown of academic impact, for papers by Kwaku Marfo Breakdown of academic impact, for papers by Marisa Mir Breakdown of academic impact, for papers by Lucile Amrouche Breakdown of academic impact, for papers by David J. Conti Breakdown of academic impact, for papers by Patricia Hirt‐Minkowski Breakdown of academic impact, for papers by Santosh Potdar Breakdown of academic impact, for papers by J. Xing
Rankless by CCL
2026